P13 Impact of ErbB Mutations on Clinical Outcomes in Afatinib- Or Erlotinib-Treated Patients With SCC of the Lung

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.07.052
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

P1.01-110 Three Specific HER2 Mutations Predict Favorable Outcomes in Advanced Lung Cancer Patients Treated With Afatinib

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P088 Distribution of Different HER2 Mutations and Their Impact on Clinical Responses to Afatinib in HER2-Mutant Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Synergistic Effect of Afatinib With Su11274 in Non-Small Cell Lung Cancer Cells Resistant to Gefitinib or Erlotinib

PLoS ONE
Multidisciplinary
2013English

The Impact of Initial Gefitinib or Erlotinib Versus Chemotherapy on Central Nervous System Progression in Advanced Non-Small Cell Lung Cancer With EGFR Mutations

Clinical Cancer Research
Cancer ResearchOncology
2012English

KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib

PLoS Medicine
BiochemistryBiotechnologyMolecular BiologyCell BiologyMedicine
2005English

Clinical Outcomes of Patients With ACS Treated With Prasugrel

Heart Lung and Circulation
Respiratory MedicinePulmonaryCardiovascular MedicineCardiology
2013English

Clinical Analysis of EGFR‐ Positive Non‐small Cell Lung Cancer Patients Treated With First‐line Afatinib: A Nagano Lung Cancer Research Group

Thoracic Cancer
MedicinePulmonaryRespiratory MedicineOncology
2019English

Prognostic Impact of [18F]Fluorothymidine and [18F]Fluoro-D-Glucose Baseline Uptakes in Patients With Lung Cancer Treated First-Line With Erlotinib

PLoS ONE
Multidisciplinary
2013English

Next-Generation Sequencing and Clinical Outcomes of Patients With Lung Adenocarcinoma Treated With Stereotactic Body Radiotherapy

Cancer
Cancer ResearchOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy